Literature DB >> 34994332

Paradoxical Septal Motion after Uncomplicated Cardiac Surgery: A Consequence of Altered Regional Right Ventricular Contractile Patterns.

Alfred Stanley1, Constantine Athanasuleas2, Navin Nanda3.   

Abstract

Paroxysmal interventricular septal motion (PSM) is the movement of the septum toward the right ventricle (RV) during cardiac systole. It occurs frequently after uncomplicated cardiac surgery (CS), including coronary bypass (on-pump and off-pump), valve repair or replacement, and with all types of incisions (sternotomy or mini-thoracotomy). It sometimes resolves quickly but may persist for months or become permanent. Global RV systolic function, stroke volume and ejection fraction remain normal after uncomplicated CS, but regional contractile patterns are altered. There is a decrease in longitudinal shortening but an increase in transverse shortening in the endocardial and epicardial right ventricular muscle fibers, respectively. PSM is a secondary event as there is no loss of septal perfusion or thickening. The increased RV transverse shortening (free wall to septal fibers) may modify septal movement resulting in PSM that compensates for the reduced RV longitudinal shortening, thus preserving normal global right ventricular function. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Paroxysmal septal motion; cardiac systole; right ventricular systolic dysfunction; tricuspid annular plane systolic excursion; tricuspid annular systolic velocity; ventricular interdependence

Mesh:

Year:  2022        PMID: 34994332     DOI: 10.2174/1573403X18666220106115117

Source DB:  PubMed          Journal:  Curr Cardiol Rev        ISSN: 1573-403X


  1 in total

Review 1.  The Interventricular Septum: Structure, Function, Dysfunction, and Diseases.

Authors:  Filippos Triposkiadis; Andrew Xanthopoulos; Konstantinos Dean Boudoulas; Grigorios Giamouzis; Harisios Boudoulas; John Skoularigis
Journal:  J Clin Med       Date:  2022-06-06       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.